ADGRF5
Basic information
Region (hg38): 6:46852522-46954943
Previous symbols: [ "GPR116" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ADGRF5 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 66 | 71 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 66 | 5 | 0 |
Variants in ADGRF5
This is a list of pathogenic ClinVar variants found in the ADGRF5 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-46854008-G-T | not specified | Likely benign (Jul 05, 2023) | ||
6-46854032-G-A | not specified | Uncertain significance (Dec 15, 2023) | ||
6-46854041-G-A | not specified | Uncertain significance (Feb 12, 2024) | ||
6-46854068-G-A | not specified | Uncertain significance (Sep 11, 2024) | ||
6-46855987-C-A | not specified | Uncertain significance (May 26, 2022) | ||
6-46858167-C-G | not specified | Uncertain significance (Jan 31, 2024) | ||
6-46858224-G-A | not specified | Uncertain significance (Jul 09, 2024) | ||
6-46858241-A-G | not specified | Uncertain significance (Oct 19, 2021) | ||
6-46858331-A-G | not specified | Uncertain significance (May 31, 2023) | ||
6-46858371-G-C | not specified | Uncertain significance (May 16, 2023) | ||
6-46858443-C-T | not specified | Uncertain significance (Dec 21, 2022) | ||
6-46858446-G-A | not specified | Uncertain significance (Dec 08, 2023) | ||
6-46858485-G-A | not specified | Uncertain significance (Dec 28, 2023) | ||
6-46858490-C-A | not specified | Uncertain significance (May 03, 2023) | ||
6-46858514-A-G | not specified | Uncertain significance (Jan 23, 2023) | ||
6-46858578-G-A | not specified | Uncertain significance (May 23, 2023) | ||
6-46858605-C-T | not specified | Uncertain significance (Jun 24, 2022) | ||
6-46858653-T-A | not specified | Uncertain significance (Aug 15, 2023) | ||
6-46858656-T-G | not specified | Uncertain significance (May 11, 2022) | ||
6-46858663-T-C | not specified | Uncertain significance (Dec 21, 2023) | ||
6-46858670-C-T | not specified | Likely benign (Nov 08, 2021) | ||
6-46858688-G-A | not specified | Uncertain significance (Jun 10, 2024) | ||
6-46858689-C-T | not specified | Uncertain significance (Dec 07, 2023) | ||
6-46858781-A-G | not specified | Uncertain significance (Feb 10, 2023) | ||
6-46858784-G-A | not specified | Uncertain significance (Aug 28, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ADGRF5 | protein_coding | protein_coding | ENST00000283296 | 20 | 102432 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0240 | 0.976 | 125713 | 0 | 35 | 125748 | 0.000139 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.635 | 677 | 725 | 0.934 | 0.0000370 | 8882 |
Missense in Polyphen | 167 | 233.49 | 0.71524 | 3005 | ||
Synonymous | -0.517 | 292 | 281 | 1.04 | 0.0000160 | 2588 |
Loss of Function | 5.22 | 15 | 57.8 | 0.260 | 0.00000257 | 714 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000239 | 0.000239 |
Ashkenazi Jewish | 0.000398 | 0.000397 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000168 | 0.000167 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.000167 | 0.000163 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Receptor that plays a critical role in lung surfactant homeostasis. May play a role in controlling adipocyte function. {ECO:0000250|UniProtKB:G5E8Q8}.;
- Pathway
- GPCRs, Other
(Consensus)
Recessive Scores
- pRec
- 0.0966
Intolerance Scores
- loftool
- rvis_EVS
- -0.74
- rvis_percentile_EVS
- 13.8
Haploinsufficiency Scores
- pHI
- 0.0200
- hipred
- N
- hipred_score
- 0.273
- ghis
- 0.496
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score
Mouse Genome Informatics
- Gene name
- Adgrf5
- Phenotype
- cellular phenotype; homeostasis/metabolism phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; growth/size/body region phenotype; vision/eye phenotype; limbs/digits/tail phenotype; skeleton phenotype; immune system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- glomerular filtration;energy reserve metabolic process;cell surface receptor signaling pathway;G protein-coupled receptor signaling pathway;glucose homeostasis;negative regulation of macrophage activation;surfactant homeostasis;fat cell differentiation;erythrocyte development;pharyngeal arch artery morphogenesis;positive regulation of phospholipid biosynthetic process
- Cellular component
- plasma membrane;cell surface;integral component of membrane;cytoplasmic vesicle;apical part of cell
- Molecular function
- G protein-coupled receptor activity